Company intelligence / Profile preview

Spectrumedix

State College, Pennsylvania, United Statessbir.gov ↗

Ownership: Private
Development stage: Other

Overview

Spectrumedix was a manufacturer of high-throughput capillary electrophoresis instruments used for DNA sequencing and genetic analysis. Their systems were widely used for applications such as comparative genome scanning, SNP genotyping, heterozygote identification, fragment sizing, PCR quality testing, and custom assay development. The company ceased operations in March 2007; subsequently, Transgenomic acquired certain assets and licensed technology to continue supporting existing customers with service and consumables[2][4].

Modalities: Device (Capillary Electrophoresis DNA Sequencer)
Industry: Molecular Diagnostics

Partnerships

Transgenomic served as the exclusive European distributor since 2003 and later acquired certain assets after closure[4].

Beyond the preview

Go deeper on Spectrumedix.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Spectrumedix.

Explore the full profile